NDC Package 70518-2451-2 Diltiazem Hydrochloride

Diltiazem Hydrochloride Extended-release Tablets Tablet, Extended Release Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70518-2451-2
Package Description:
90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product Code:
Proprietary Name:
Diltiazem Hydrochloride
Non-Proprietary Name:
Diltiazem Hydrochloride Extended-release Tablets
Substance Name:
Diltiazem Hydrochloride
Usage Information:
Diltiazem Hydrochloride Extended-Release Tablets are contraindicated in:Patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker. Patients with second- or third-degree AV block except in the presence of a functioning ventricular pacemaker. Patients with hypotension (less than 90 mm Hg systolic). Patients who have demonstrated hypersensitivity to the drug. Patients with acute myocardial infarction and pulmonary.
11-Digit NDC Billing Format:
70518245102
NDC to RxNorm Crosswalk:
  • RxCUI: 830879 - dilTIAZem hydrochloride 240 MG 24HR Extended Release Oral Tablet
  • RxCUI: 830879 - 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Tablet
  • RxCUI: 830879 - diltiazem hydrochloride 240 MG 24 HR Extended Release Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Remedyrepack Inc.
    Dosage Form:
    Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA021392
    Marketing Category:
    NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
    Start Marketing Date:
    11-25-2019
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70518-2451-2?

    The NDC Packaged Code 70518-2451-2 is assigned to a package of 90 tablet, extended release in 1 bottle, plastic of Diltiazem Hydrochloride, a human prescription drug labeled by Remedyrepack Inc.. The product's dosage form is tablet, extended release and is administered via oral form.

    Is NDC 70518-2451 included in the NDC Directory?

    Yes, Diltiazem Hydrochloride with product code 70518-2451 is active and included in the NDC Directory. The product was first marketed by Remedyrepack Inc. on November 25, 2019 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 70518-2451-2?

    The 11-digit format is 70518245102. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-170518-2451-25-4-270518-2451-02